BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Thyroid cancer AND NRG1, ENSG00000157168, 3084, SMDF, NDF, HRGA, HRG1, HGL, GGF2, GGF, ARIA
17 results:

  • 1. Yap governs a lineage-specific neuregulin1 pathway-driven adaptive resistance to RAF kinase inhibitors.
    Garcia-Rendueles MER; Krishnamoorthy G; Saqcena M; Acuña-Ruiz A; Revilla G; de Stanchina E; Knauf JA; Lester R; Xu B; Ghossein RA; Fagin JA
    Mol Cancer; 2022 Dec; 21(1):213. PubMed ID: 36476495
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Long-Term Follow-Up on Morbidity Among Women With a History of Gestational Diabetes Mellitus: A Systematic Review.
    Flachs Madsen LR; Gerdøe-Kristensen S; Lauenborg J; Damm P; Kesmodel US; Lynge E
    J Clin Endocrinol Metab; 2022 Aug; 107(9):2411-2423. PubMed ID: 35763540
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Safety and Efficacy of Percutaneous Cryoablation of Extraspinal thyroid cancer Bone Metastases with Curative Intent: Single-Center Experience with a Median Follow-up of More than 5 Years.
    Autrusseau PA; Schneegans O; Koch G; Weiss J; Caudrelier J; Dalili D; Perolat R; Auloge P; Cazzato RL; Gangi A; Garnon J
    J Vasc Interv Radiol; 2022 Jul; 33(7):797-804. PubMed ID: 35318124
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Gene network and biological pathways associated with susceptibility to differentiated thyroid carcinoma.
    Kulkarni O; Sugier PE; Guibon J; Boland-Augé A; Lonjou C; Bacq-Daian D; Olaso R; Rubino C; Souchard V; Rachedi F; Lence-Anta JJ; Ortiz RM; Xhaard C; Laurent-Puig P; Mulot C; Guizard AV; Schvartz C; Boutron-Ruault MC; Ostroumova E; Kesminiene A; Deleuze JF; Guénel P; De Vathaire F; Truong T; Lesueur F
    Sci Rep; 2021 Apr; 11(1):8932. PubMed ID: 33903625
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The Contribution of Genetic Variants to the Risk of Papillary thyroid Carcinoma in the Kazakh Population: Study of Common Single Nucleotide Polymorphisms and Their Clinicopathological Correlations.
    Mussazhanova Z; Rogounovitch TI; Saenko VA; Krykpayeva A; Espenbetova M; Azizov B; Kondo H; Matsuda K; Kalmatayeva Z; Issayeva R; Yeleubayeva Z; Madiyeva M; Mukanova A; Sandybayev M; Bolsynbekova S; Kozykenova Z; Yamashita S; Nakashima M
    Front Endocrinol (Lausanne); 2020; 11():543500. PubMed ID: 33551988
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. nrg1 regulates redox homeostasis via NRF2 in papillary thyroid cancer.
    Zhang TT; Qu N; Sun GH; Zhang L; Wang YJ; Mu XM; Wei WJ; Wang YL; Wang Y; Ji QH; Zhu YX; Shi RL
    Int J Oncol; 2018 Aug; 53(2):685-693. PubMed ID: 29901070
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The Role of nrg1 in the Predisposition to Papillary thyroid Carcinoma.
    He H; Li W; Liyanarachchi S; Wang Y; Yu L; Genutis LK; Maharry S; Phay JE; Shen R; Brock P; de la Chapelle A
    J Clin Endocrinol Metab; 2018 Apr; 103(4):1369-1379. PubMed ID: 29121253
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Genome-wide association and expression quantitative trait loci studies identify multiple susceptibility loci for thyroid cancer.
    Son HY; Hwangbo Y; Yoo SK; Im SW; Yang SD; Kwak SJ; Park MS; Kwak SH; Cho SW; Ryu JS; Kim J; Jung YS; Kim TH; Kim SJ; Lee KE; Park DJ; Cho NH; Sung J; Seo JS; Lee EK; Park YJ; Kim JI
    Nat Commun; 2017 Jul; 8():15966. PubMed ID: 28703219
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Papillary thyroid Carcinoma: Association Between Germline DNA Variant Markers and Clinical Parameters.
    Jendrzejewski J; Liyanarachchi S; Nagy R; Senter L; Wakely PE; Thomas A; Nabhan F; He H; Li W; Sworczak K; Ringel MD; Kirschner LS; de la Chapelle A
    Thyroid; 2016 Sep; 26(9):1276-84. PubMed ID: 27342578
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The common genetic variant rs944289 on chromosome 14q13.3 associates with risk of both malignant and benign thyroid tumors in the Japanese population.
    Rogounovitch TI; Bychkov A; Takahashi M; Mitsutake N; Nakashima M; Nikitski AV; Hayashi T; Hirokawa M; Ishigaki K; Shigematsu K; Bogdanova T; Matsuse M; Nishihara E; Minami S; Yamanouchi K; Ito M; Kawaguchi T; Kondo H; Takamura N; Ito Y; Miyauchi A; Matsuda F; Yamashita S; Saenko VA
    Thyroid; 2015 Mar; 25(3):333-40. PubMed ID: 25562676
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Anchored multiplex PCR for targeted next-generation sequencing.
    Zheng Z; Liebers M; Zhelyazkova B; Cao Y; Panditi D; Lynch KD; Chen J; Robinson HE; Shim HS; Chmielecki J; Pao W; Engelman JA; Iafrate AJ; Le LP
    Nat Med; 2014 Dec; 20(12):1479-84. PubMed ID: 25384085
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Medical morbidities in endometrial cancer patients.
    Tangjitgamol S; Khunnarong J; Srijaipracharoen S
    Int J Gynecol Cancer; 2014 Nov; 24(9):1623-7. PubMed ID: 25275662
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Genome-wide association study on differentiated thyroid cancer.
    Köhler A; Chen B; Gemignani F; Elisei R; Romei C; Figlioli G; Cipollini M; Cristaudo A; Bambi F; Hoffmann P; Herms S; Kalemba M; Kula D; Harris S; Broderick P; Houlston R; Pastor S; Marcos R; Velázquez A; Jarzab B; Hemminki K; Landi S; Försti A
    J Clin Endocrinol Metab; 2013 Oct; 98(10):E1674-81. PubMed ID: 23894154
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Relief of feedback inhibition of HER3 transcription by RAF and MEK inhibitors attenuates their antitumor effects in BRAF-mutant thyroid carcinomas.
    Montero-Conde C; Ruiz-Llorente S; Dominguez JM; Knauf JA; Viale A; Sherman EJ; Ryder M; Ghossein RA; Rosen N; Fagin JA
    Cancer Discov; 2013 May; 3(5):520-33. PubMed ID: 23365119
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Discovery of common variants associated with low TSH levels and thyroid cancer risk.
    Gudmundsson J; Sulem P; Gudbjartsson DF; Jonasson JG; Masson G; He H; Jonasdottir A; Sigurdsson A; Stacey SN; Johannsdottir H; Helgadottir HT; Li W; Nagy R; Ringel MD; Kloos RT; de Visser MC; Plantinga TS; den Heijer M; Aguillo E; Panadero A; Prats E; Garcia-Castaño A; De Juan A; Rivera F; Walters GB; Bjarnason H; Tryggvadottir L; Eyjolfsson GI; Bjornsdottir US; Holm H; Olafsson I; Kristjansson K; Kristvinsson H; Magnusson OT; Thorleifsson G; Gulcher JR; Kong A; Kiemeney LA; Jonsson T; Hjartarson H; Mayordomo JI; Netea-Maier RT; de la Chapelle A; Hrafnkelsson J; Thorsteinsdottir U; Rafnar T; Stefansson K
    Nat Genet; 2012 Jan; 44(3):319-22. PubMed ID: 22267200
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Heregulin-dependent autocrine loop regulates growth of K-ras but not erbB-2 transformed rat thyroid epithelial cells.
    Mincione G; Piccirelli A; Lazzereschi D; Salomon DS; Colletta G
    J Cell Physiol; 1998 Aug; 176(2):383-91. PubMed ID: 9648926
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Site-specifically radioiodinated antibody for targeting tumors.
    Rea DW; Ultee ME; Belinka BA; Coughlin DJ; Alvarez VL
    Cancer Res; 1990 Feb; 50(3 Suppl):857s-861s. PubMed ID: 2297734
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.